Wednesday, October 24, 2018 5:25:03 PM
I like the fact that Recli just (Monday) bought 200k more shares at about .40, AFTER buying 500k shares at .25. Yes, Day traders added to the fun here, but we’re headed for better times/higher valuations. The opioid bill/laws will make TTNP’s future, in facilitating OUD/treatment administration, and making payment easier, more accessible, more available and acceptable to providers. Pain market will be next. Huge. I too can easily see a buyout...a bigger better pharma can really take all of this to the next levels. Day traders may bail out. Shorts may reek momentary havoc...I’ll be adding on the downdraft, if any. Best to all.
Recent TTNP News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 10/14/2025 08:05:15 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/09/2025 09:30:37 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/09/2025 09:30:34 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/09/2025 09:21:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2025 12:21:28 AM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 10/02/2025 12:47:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2025 08:05:34 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/22/2025 04:28:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/14/2025 09:16:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/22/2025 09:06:53 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 07/22/2025 09:04:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2025 08:15:19 PM
- Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 06/27/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2025 08:49:02 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/03/2025 09:25:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2025 09:25:13 PM
- Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. • GlobeNewswire Inc. • 06/03/2025 12:45:44 PM
